AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Zepbound vs Wegovy trial and compounded GLP-1s
Docs Who Lift
Intro
This chapter examines the SURMOUNT-5 trial findings, comparing the efficacy of Zepbound and Wegovy for obesity treatment. It also discusses the implications of recent ADA discussions on GLP-1 agonists and upcoming FDA legislative changes affecting diabetes and obesity interventions.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode